Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Neural stem cells take a step closer to the clinic

10.06.2003


Scientists working with cells that may someday be used to replace diseased or damaged cells in the brain have taken neural stem cell technology a key step closer to the clinic.

Writing in the current online edition (June 2003) of the Journal of Neurochemistry, scientists from the University of Wisconsin-Madison’s Waisman Center describe the first molecular profile for human fetal neural stem cell lines that have been coaxed to thrive in culture for more than a year.

The work is an in-depth analysis of global gene expression in human neural stem cells and demonstrates a method for prolonging the shelf life of cultured fetal stem cells, making it possible to generate enough cells to use to treat disease, says Lynda Wright, the lead author of the paper.



"We have now characterized long-term neural stem cells lines," she says. "That genetic characterization - and our ability to grow these lines for a year or more - is one of the major steps toward clinical application."

Unlike human embryonic stem cells, stem cells derived from fetal tissue are not capable of growing in culture indefinitely. But because neural fetal stem cells have been available to science for a much longer period than cells derived from embryos, their capabilities are better known to scientists and they may reach the clinic as therapies for disorders like Parkinson’s and amyotrophic lateral sclerosis (ALS) much sooner.

In culture, the cells can be coaxed into becoming "neurospheres," aggregates of precursor brain cells that, when implanted, can migrate to different parts of the brain, integrate themselves and develop into many of the different types of specialized cells that make up the brain.

"These cells are the basis for future therapies. These are the cells we want to transplant," said Clive Svendsen, senior author of the Journal of Neurochemistry paper and a leading authority on neural stem cells.

But scientists have been limited by the tendency of these cells to peter out in culture, making it difficult to generate quantities that could be used therapeutically. The Wisconsin team reported work on three cell lines that were kept growing and dividing in culture for 50 weeks.

The Wisconsin researchers were able to extend the shelf life of the neural stem cell lines by adding a signaling chemical known as leukemia inhibitory factor to the medium in which the cells were grown.

The cells were then subjected to "gene chip" analysis, a powerful method for scanning the activity of thousands of genes at once. Nearly 33,000 genes were monitored across the three cell lines to chart genetic activity. Knowing what genes are at work is critical for characterizing and preparing cells for use in transplant therapy.

"This is the first real genetic analysis of neural stem cells," says Svendsen. "It is like creating a library and a bank at the same time."

By tuning in to the genes that are at work in the neurospheres, scientists will be able to gain the molecular insight necessary to create cells that can be customized for therapy. For example, the Wisconsin group was able to monitor the activity of genes that influence immune response.

A critical hurdle for any cells or tissue used in transplants is finding ways to get around the body’s immune system, which targets foreign cells and tissue for rejection. Through genetic manipulation, it may be possible to create cells that fool the immune system, obviating the need for drugs to suppress the immune system in order for the transplant to be accepted by the body.

"We saw a huge number of MHC (major histocompatibility complex) genes that were affected," Svendsen says. "This is how cell surfaces are influenced so that the immune system can recognize them."

Svendsen emphasizes that while the new work represents necessary and key steps on the path to clinical use of stem cells, much work remains to be done before such cells are used in therapy.

"This gets us closer," he says. "But we still have a lot of work to do before these cells achieve their promise as treatments for neural diseases."

Svendsen says the data from the gene chip analysis would be placed online and made available to other researchers studying neural stem cells.

Other co-authors of the paper include Jiang Li, Kyle Wallace and Jeffrey A. Johnson, also of UW-Madison, and Maeve A. Caldwell of the University of Cambridge. The work was funded by grants from the Wellcome Trust, the Michael J. Fox Foundation and the Environmental Health Science Center.

Lynda Wright | University of Wisconsin
Further information:
http://www.news.wisc.edu/releases/view.html?id=8719

More articles from Life Sciences:

nachricht First use of vasoprotective antibody in cardiogenic shock
17.05.2019 | Deutsches Zentrum für Herz-Kreislauf-Forschung e.V.

nachricht A nerve cell serves as a “single” for studies
15.05.2019 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Self-repairing batteries

UTokyo engineers develop a way to create high-capacity long-life batteries

Engineers at the University of Tokyo continually pioneer new ways to improve battery technology. Professor Atsuo Yamada and his team recently developed a...

Im Focus: Quantum Cloud Computing with Self-Check

With a quantum coprocessor in the cloud, physicists from Innsbruck, Austria, open the door to the simulation of previously unsolvable problems in chemistry, materials research or high-energy physics. The research groups led by Rainer Blatt and Peter Zoller report in the journal Nature how they simulated particle physics phenomena on 20 quantum bits and how the quantum simulator self-verified the result for the first time.

Many scientists are currently working on investigating how quantum advantage can be exploited on hardware already available today. Three years ago, physicists...

Im Focus: Accelerating quantum technologies with materials processing at the atomic scale

'Quantum technologies' utilise the unique phenomena of quantum superposition and entanglement to encode and process information, with potentially profound benefits to a wide range of information technologies from communications to sensing and computing.

However a major challenge in developing these technologies is that the quantum phenomena are very fragile, and only a handful of physical systems have been...

Im Focus: A step towards probabilistic computing

Working group led by physicist Professor Ulrich Nowak at the University of Konstanz, in collaboration with a team of physicists from Johannes Gutenberg University Mainz, demonstrates how skyrmions can be used for the computer concepts of the future

When it comes to performing a calculation destined to arrive at an exact result, humans are hopelessly inferior to the computer. In other areas, humans are...

Im Focus: Recording embryonic development

Scientists develop a molecular recording tool that enables in vivo lineage tracing of embryonic cells

The beginning of new life starts with a fascinating process: A single cell gives rise to progenitor cells that eventually differentiate into the three germ...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

SEMANTiCS 2019 brings together industry leaders and data scientists in Karlsruhe

29.04.2019 | Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

First dust conference in the Central Asian part of the earth’s dust belt

15.04.2019 | Event News

 
Latest News

Discovering unusual structures from exception using big data and machine learning techniques

17.05.2019 | Materials Sciences

ALMA discovers aluminum around young star

17.05.2019 | Physics and Astronomy

A new iron-based superconductor stabilized by inter-block charger transfer

17.05.2019 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>